Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Search

Reset Filter
You have a filtered search result

11 search results for ‘*’


Business & Regulation Business Practice

Fourth Time’s a Charm

| James Strachan

We sit down with Nigel Theobald, Chief Executive, N4 Pharma. He tells us the story of his career and offers some advice for budding entrepreneurs.


Business & Regulation Business Practice

Solutions In... Human Antibodies

| Maryam Mahdi

John McCafferty, CEO of IONTAS, explains how his company’s work in mammalian cells could bring biopharmaceuticals to market faster.


Discovery & Development Drug Discovery

Bright SPARK

| Maryam Mahdi

Representing a powerful example of collaboration between industry and academia is SPARK – a program helping accelerate the drug development process.


Discovery & Development Drug Discovery

The (Secret) Barrier Breaker

| Maryam Mahdi

Sitting Down With… Steve Arlington, President at the Pistoia Alliance.


Discovery & Development Drug Discovery

Solutions In… the Skin-Biome

| Maryam Mahdi

At the helm of SkinBioTherapeutics, Catherine O’Neill and her team are exploring the ways in which probiotic bacteria can be used topically.


Manufacture Formulation

Formulation Fail

| Stephanie Sutton

Delays arising from formulation issues are commonplace in the industry. It’s time to start thinking about the problem earlier.


Manufacture Ingredients

A Lifetime of Achievement

| Maryam Mahdi

Sitting Down With... David Schoneker, Global Regulatory Director, Strategic Relationships at Colorcon.


Manufacture Business Practice

Scottish Pride and Innovation

| Stephanie Sutton

Sitting Down With… Dave Tudor, Managing Director of the Medicines Manufacturing Innovation Centre (MMIC), Scotland, UK.


Discovery & Development Clinical Trials

With Age Comes Challenges But Not Trials

| Maryam Mahdi, Stephanie Sutton

A key focus of Andrew McLachlan’s career is understanding the impact of aging on drug disposition and response to medicines.


Business & Regulation Business Practice

Staying the Course

| James Strachan

Sitting Down With… Stanley Crooke, Chairman of the Board & Chief Executive Officer at Ionis Pharmaceuticals.


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register